| Literature DB >> 35325275 |
Fang Luo1, PinAng Zou1, Yinqian Liao1, Jiaze Luo1, Dan Luo1, Kuan Hu1, KaiXuan Zhang1, BaoGuo Wang2.
Abstract
Tuberculosis (TB) is an important public health problem. Studies indicated that TAP plays a key role in the presentation and transport of antigenic peptides during anti-M.tb infection. Given the important biological role of the TAP gene involved in anti-M.tb infection, a family-based case-control study including 133 tuberculosis patients, 107 healthy household contacts, and 173 healthy controls was conducted to assess the association between TAP gene polymorphisms and TB susceptibility. The basic information of subjects and their blood samples were collected. Four SNPs including rs1135216, rs1057141, rs241447, and rs3819721 were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Our results suggested that BMI, residence, bedroom crowding, indoor humidity, fitness activities, history of smoking, and TB exposure history were associated with the occurrence of tuberculosis (P < 0.05). A significant association was observed between the TAP1 rs1135216 CT/CC genotype and increased TB risk, and the ORs were 2.56 (95% CI 1.31-4.99) and 6.73 (95% CI 1.33-34.02), respectively. TAP2 rs3819721 GG genotype carriers also showed an increased risk of TB when compared TB patients to healthy household contacts. Haplotype analysis revealed that the haplotype CT at rs1057141 and rs1135216 (OR = 11.34, 95% CI 1.49-86.56; OR = 7.45, 95% CI 1.43-38.76), as well as TA at rs241447 and rs3819721 (OR = 2.20, 95% CI 1.07-4.56) had a significantly increased risk of TB. The genetic risk scores (GRS) analysis of the four loci indicated that the risk of tuberculosis increased with increasing GRS scores in TB vs HHC (Ptrend = 0.010) and in TB vs HC (Ptrend = 0.001). In conclusion, our findings suggested that the SNPs of rs1135216 and rs3819721 were associated with TB susceptibility among the tuberculosis-prone families in the Chinese Han population and the risk of developing tuberculosis increases with the number of risk alleles, which could help identify high-risk groups in time and take scientific preventive measures. Further cohort studies with large samples are needed to validate the role of TAP gene variants on TB susceptibility.Entities:
Keywords: Genetic risk score; Haplotype; Transporter-associated antigen processing; Tuberculosis-prone families
Mesh:
Year: 2022 PMID: 35325275 PMCID: PMC8943507 DOI: 10.1007/s00438-022-01885-3
Source DB: PubMed Journal: Mol Genet Genomics ISSN: 1617-4623 Impact factor: 3.291
Demographic characteristics of TB (patients), HHC (healthy household contacts) and HC (healthy controls)
| Variable | TB, | HHC, | HC, | TB vs HHC | TB vs HC | ||
|---|---|---|---|---|---|---|---|
| Age | 16.214 | 0.001 | 1.12 | 0.773 | |||
| ≤ 24 | 17 (12.8) | 35 (32.7) | 23 (13.3) | ||||
| 25–34 | 25 (18.8) | 20 (18.7) | 39 (22.5) | ||||
| 35–44 | 18 (13.5) | 15 (14.0) | 26 (15.0) | ||||
| ≥ 45 | 73 (54.9) | 37(34.6) | 85 (49.1) | ||||
| Gender | 14.56 | < 0.001 | 19.91 | < 0.001 | |||
| Male | 91 (68.4) | 47 (43.9) | 74 (42.8) | ||||
| Female | 42 (31.6) | 60 (56.1) | 99 (57.2) | ||||
| Level of education | 2.00 | 0.367 | 47.44 | < 0.001 | |||
| Junior and below | 93 (69.9) | 83 (77.6) | 62 (35.8) | ||||
| Senior high school | 29 (21.8) | 16 (15.0) | 40 (23.1) | ||||
| Undergraduate and above | 11 (8.3) | 8 (7.5) | 71 (41.0) | ||||
| Occupations | 20.44 | 0.001 | 48.12 | < 0.001 | |||
| Students | 4 (3.0) | 22 (20.6) | 9 (5.2) | ||||
| Business | 18 (13.5) | 11 (10.3) | 25 (14.5) | ||||
| Public officials | 11 (8.3) | 8 (7.5) | 64 (37.0) | ||||
| Workers | 33 (24.8) | 16 (15.0) | 23 (13.3) | ||||
| Farmers | 25 (18.8) | 18 (16.8) | 7 (4.0) | ||||
| Others | 42 (31.6) | 32 (29.9) | 45 (26.0) | ||||
Comparison of environmental factors between TB (patients) and HHC (healthy household contacts)
| Variable | Total | TB, | HHC, | ||
|---|---|---|---|---|---|
| BMI (kg/m2) | 240 | 0.95 | 0.330 | ||
| ≤ 18.5 | 60 | 30 (22.6) | 30 (28.0) | ||
| > 18.5 | 180 | 103 (77.4) | 77 (72.0) | ||
| Medical insurance | 240 | 2.65 | 0.103 | ||
| No | 29 | 11 (8.3) | 16 (15.0) | ||
| Yes | 211 | 122 (91.7) | 91 (85.0) | ||
| Monthly household income | 240 | 1.07 | 0.586 | ||
| ≤ 3000 | 79 | 46 (34.6) | 33 (30.8) | ||
| 3001–7999 | 110 | 57 (42.9) | 53 (49.5) | ||
| ≥ 8000 | 51 | 30 (22.6) | 21 (19.6) | ||
| Smoking status | 240 | 32.89 | < 0.001 | ||
| Yes | 83 | 67 (50.4) | 16 (15.0) | ||
| No | 157 | 66 (49.6) | 91(85.0) | ||
| Drinking status | 240 | 1.35 | 0.245 | ||
| Yes | 65 | 40 (30.1) | 25 (23.4) | ||
| No | 175 | 93 (69.9) | 82 (76.6) | ||
| Fitness activities | 240 | 6.46 | 0.011 | ||
| Yes | 93 | 42 (31.6) | 51 (47.7) | ||
| No | 147 | 91 (68.4) | 56 (52.3) | ||
| BCG vaccine | 240 | 1.50 | 0.221 | ||
| Yes | 149 | 78 (58.6) | 71 (66.4) | ||
| No | 91 | 55 (41.4) | 36 (33.6) | ||
| History of TB exposure | 240 | 5.54 | 0.019 | ||
| Yes | 225 | 120 (90.2) | 85 (79.4) | ||
| No | 15 | 13 (9.8) | 22 (20.6) |
BMI body mass index, BCG vaccine Bacillus Calmette Guerin vaccine
Comparison of environmental factors between TB (patients) and HC (healthy controls)
| Variable | Total | TB, | HC, | ||
|---|---|---|---|---|---|
| BMI (kg/m2) | 306 | 12.78 | < 0.001 | ||
| ≤ 18.5 | 44 | 30 (22.6) | 14 (8.1) | ||
| > 18.5 | 262 | 103 (77.4) | 159 (91.9) | ||
| Medical insurance | 306 | 2.42 | 0.120 | ||
| No | 18 | 11 (8.3) | 7(4.0) | ||
| Yes | 288 | 122 (91.7) | 166 (96.0) | ||
| Monthly household income | 306 | 16.37 | < 0.001 | ||
| ≤ 3000 | 82 | 46 (34.6) | 36 (20.8) | ||
| 3001–7999 | 118 | 57 (42.9) | 61 (35.3) | ||
| ≥ 8000 | 106 | 30 (22. 6) | 76 (43.9) | ||
| Smoking status | 306 | 39.46 | < 0.001 | ||
| Yes | 101 | 67 (50.4) | 29 (16.8) | ||
| No | 205 | 66 (49.6) | 144 (83.2) | ||
| Drinking status | 306 | 2.48 | 0.116 | ||
| Yes | 107 | 40 (30.1) | 67 (38.7) | ||
| No | 199 | 93 (69.9) | 106 (61.3) | ||
| Fitness activities | 306 | 40.44 | < 0.001 | ||
| Yes | 160 | 42 (31.6) | 118 (68.2) | ||
| No | 146 | 91 (68.4) | 55 (31.8) | ||
| Residence | 306 | 44.68 | < 0.001 | ||
| Rural | 134 | 87 (65.4) | 47 (27.2) | ||
| Towns | 172 | 46 (34.6) | 126 (72.8) | ||
| Bedroom occupants | 306 | 17.62 | < 0.001 | ||
| ≤ 1 person/room | 99 | 26 (19.5) | 73 (42.2) | ||
| ≥ 2 person/room | 207 | 107 (80.5) | 100 (57.8) | ||
| Indoor ventilation | 306 | 1.70 | 0.192 | ||
| Everyday | 270 | 121 (91.0) | 149 (86.1) | ||
| Definite time | 36 | 12 (9.0) | 24 (13.9) | ||
| Indoor humidity | 306 | 4.51 | 0.034 | ||
| Dry | 208 | 34 (25.6) | 64 (37.0) | ||
| Moist | 98 | 99 (74.4) | 109 (63.0) | ||
| Indoor lighting | 306 | 14.19 | < 0.001 | ||
| Good | 216 | 79 (59.4) | 137 (79.2) | ||
| General | 90 | 54 (40.6) | 36 (20.8) | ||
| Indoor sanitation | 306 | 15.99 | < 0.001 | ||
| Good | 234 | 87 (65.4) | 147 (85.0) | ||
| General | 72 | 46 (34.6) | 26 (15.0) | ||
| BCG vaccine | 306 | 15.76 | < 0.001 | ||
| Yes | 166 | 55 (41.4) | 111 (64.2) | ||
| No | 140 | 78 (58.6) | 62 (35.8) | ||
| History of TB exposure | 306 | 79.11 | < 0.001 | ||
| Yes | 190 | 120 (90.2) | 70 (17.9) | ||
| No | 116 | 13 (9.8) | 103 (82.1) |
BMI body mass index, BCG vaccine Bacillus Calmette Guerin vaccine
Multivariate logistic regression analysis of risk factors regarding TB vs HHC and TB vs HC
| Group | Variable | Standard deviation | OR | 95% CI | |||
|---|---|---|---|---|---|---|---|
| TB vs HHC | Age | ||||||
| ≤ 24 | 1.00 | ||||||
| 25–34 | 0.14 | 0.55 | 0.07 | 0.796 | 1.15 | 0.39–3.38 | |
| 35–44 | 0.41 | 0.59 | 0.47 | 0.493 | 1.50 | 0.47–4.79 | |
| ≥ 45 | 1.01 | 0.52 | 3.68 | 0.055 | 2.73 | 0.98–7.63 | |
| Gender | |||||||
| Male | 1.00 | ||||||
| Female | − 0.56 | 0.39 | 2.06 | 0.151 | 0.57 | 0.27–1.23 | |
| Occupations | |||||||
| Students | 1.00 | ||||||
| Business | 1.58 | 0.82 | 3.77 | 0.052 | 4.88 | 0.99–24.11 | |
| Public officials | 1.10 | 0.90 | 1.49 | 0.223 | 3.00 | 0.51–17.55 | |
| Workers | 1.45 | 0.75 | 3.72 | 0.054 | 4.27 | 0.98–18.67 | |
| Farmers | 1.28 | 0.82 | 2.40 | 0.121 | 3.59 | 0.71–18.02 | |
| Others | 1.25 | 0.73 | 2.94 | 0.086 | 3.49 | 0.84–14.56 | |
| Smoking status | |||||||
| No | 1.00 | ||||||
| Yes | 1.28 | 0.43 | 8.75 | 0.003 | 3.61 | 1.54–8.45 | |
| Fitness activities | |||||||
| No | 1.00 | ||||||
| Yes | − 0.66 | 0.32 | 4.30 | 0.038 | 0.52 | 0.28–0.96 | |
| History of TB exposure | |||||||
| No | 1.00 | ||||||
| Yes | 1.09 | 0.45 | 6.02 | 0.014 | 2.99 | 1.25–7.16 | |
| TB vs HC | Gender | ||||||
| Male | 1.00 | ||||||
| Female | − 0.56 | 0.48 | 1.36 | 0.244 | 0.57 | 0.23–1.46 | |
| Level of education | |||||||
| Junior and below | 1.00 | ||||||
| Senior high school | 0.27 | 0.46 | 0.33 | 0.563 | 1.30 | 0.53–3.21 | |
| Undergraduate and above | − 1.10 | 0.57 | 3.77 | 0.052 | 0.33 | 0.11–1.01 | |
| Occupations | |||||||
| Students | 1.00 | ||||||
| Business | 0.17 | 1.07 | 0.02 | 0.877 | 1.18 | 0.15–9.57 | |
| Public officials | − 0.23 | 1.04 | 0.05 | 0.824 | 0.79 | 0.10–6.13 | |
| Workers | 0.68 | 1.01 | 0.46 | 0.498 | 1.98 | 0.28–14.23 | |
| Farmers | 1.56 | 1.12 | 1.93 | 0.165 | 4.75 | 0.53–42.77 | |
| Others | 0.16 | 1.00 | 0.03 | 0.871 | 1.18 | 0.17–8.34 | |
| BMI (kg/m | |||||||
| ≤ 18.5 | 1.00 | ||||||
| > 18.5 | − 1.20 | 0.56 | 4.62 | 0.032 | 0.30 | 0.10–0.90 | |
| Monthly household income | |||||||
| ≤ 3000 | 1.00 | ||||||
| 3001–7999 | 0.22 | 0.46 | 0.23 | 0.630 | 1.25 | 0.51–3.09 | |
| ≥ 8000 | − 0.16 | 0.51 | 0.09 | 0.762 | 0.86 | 0.31–2.34 | |
| Smoking status | |||||||
| No | 1.00 | ||||||
| Yes | 1.00 | 0.49 | 4.11 | 0.043 | 2.72 | 1.03–7.15 | |
| Fitness activities | |||||||
| No | 1.00 | ||||||
| Yes | − 0.90 | 0.39 | 5.48 | 0.019 | 0.41 | 0.19–0.86 | |
| Residence | |||||||
| Rural | 1.00 | ||||||
| towns | − 0.96 | 0.40 | 5.83 | 0.016 | 0.38 | 0.18–0.84 | |
| Bedroom occupants | |||||||
| ≤ 1 person/room | 1.00 | ||||||
| ≥ 2 person/room | 1.27 | 0.41 | 9.85 | 0.002 | 3.56 | 1.61–7.89 | |
| Indoor humidity | |||||||
| Dry | 1.00 | ||||||
| Moist | 1.01 | 0.46 | 4.95 | 0.026 | 2.75 | 1.13–6.70 | |
| Indoor lighting | |||||||
| Good | 1.00 | ||||||
| General | 0.48 | 0.43 | 1.21 | 0.271 | 1.61 | 0.69–3.75 | |
| Indoor sanitation | |||||||
| Good | 1.00 | ||||||
| General | 0.95 | 0.50 | 3.70 | 0.054 | 2.60 | 0.98–6.84 | |
| BCG vaccine | |||||||
| Yes | 1.00 | ||||||
| No | − 0.60 | 0.37 | 2.65 | 0.104 | 0.55 | 0.27–1.13 | |
| History of TB exposure | |||||||
| No | 1.00 | ||||||
| Yes | 2.56 | 0.46 | 31.46 | < 0.001 | 12.93 | 5.29–31.61 |
BMI body mass index, BCG vaccine Bacillus Calmette Guerin vaccine
Genotype and allele distribution of TAP1 rs1135216 and rs1057141 in TB, HHC and HC
| SNPs | Genetic model | Genotype/allele | TB, | HHC, | HC, | TB vs HHC | TB vs HC | ||
|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI)a | OR (95% CI)b | ||||||||
| rs1135216 | Co-dominant | TT | 75 (56.4) | 81 (75.7) | 125 (72.2) | 1.00 | 0.002 | 1.00 | 0.092 |
| CT | 48 (36.1) | 24 (22.4) | 46 (26.6) | 2.56 (1.31–4.99) | 1.67 (0.82–3.43) | ||||
| CC | 10 (7.5) | 2 (1.9) | 2 (1.2) | 6.73 (1.33–34.02) | 5.48 (0.76–39.53) | ||||
| Dominant | TT | 75 (56.4) | 81 (75.7) | 125 (72.2) | 1.00 | 0.001 | 1.00 | 0.072 | |
| CT–CC | 58 (43.6) | 26 (24.3) | 48 (27.8) | 2.92 (1.55–5.53) | 1.88 (0.94–3.77) | ||||
| Recessive | TT–CT | 123 (92.5) | 105 (98.1) | 171 (98.8) | 1.00 | 0.025 | 1.00 | 0.094 | |
| CC | 10 (7.5) | 2 (1.9) | 2 (1.2) | 5.14 (1.04–25.53) | 4.49 (0.63–31.84) | ||||
| Super-dominance | TT–CC | 85 (63.9) | 83 (77.6) | 127 (73.4) | 1.00 | 0.010 | 1.00 | 0.271 | |
| CT | 48 (36.1) | 24 (22.4) | 46 (26.6) | 2.28 (1.1.18–4.39) | 1.48 (0.73–2.99) | ||||
| Alleles | T | 198 (74.4) | 186 (86.9) | 296 (85.5) | 1.00 | < 0.001 | 1.00 | 0.001 | |
| C | 68 (25.6) | 28 (13.1) | 50 (14.5) | 2.28 (1.41–3.70) | 2.03 (1.35–3.06) | ||||
| rs1057141 | Co-dominant | TT | 70 (52.6) | 50 (46.7) | 103 (59.5) | 1.00 | 0.930 | 1.00 | 0.732 |
| CT | 53 (39.9) | 50 (46.7) | 59 (34.1) | 0.89 (0.50–1.60) | 1.29 (0.64–2.58) | ||||
| CC | 10 (7.5) | 7 (6.5) | 11 (6.4) | 0.98 (0.32–2.99) | 0.89 (0.27–2.97) | ||||
| Dominant | TT | 70 (52.6) | 50 (46.7) | 103 (59.5) | 1.00 | 0.721 | 1.00 | 0.582 | |
| CT–CC | 63 (47.4) | 57 (53.3) | 70 (40.5) | 0.90 (0.51–1.59) | 1.20 (0.62–2.31) | ||||
| Recessive | TT–CT | 123 (92.5) | 100 (93.5) | 162 (93.6) | 1.00 | 0.962 | 1.00 | 0.723 | |
| CC | 10 (7.5) | 7 (6.5) | 11 (6.4) | 1.03 (0.35–3.05) | 0.81 (0.25–2.59) | ||||
| Super-dominance | TT–CC | 80 (60.1) | 57 (53.3) | 114 (65.9) | 1.00 | 0.734 | 1.00 | 0.441 | |
| CT | 53 (39.9) | 50 (46.7) | 59 (34.1) | 0.89 (0.51–1.58) | 1.31 (0.66–2.57) | ||||
| Alleles | T | 193 (72.6) | 150 (70.1) | 265 (76.6) | 1.00 | 0.553 | 1.00 | 0.254 | |
| C | 73 (27.4) | 64 (29.9) | 81 (23.4) | 0.89 (0.60–1.32) | 1.24 (0.86–1.79) | ||||
| rs241447 | Co-dominant | TT | 63 (47.4) | 42 (39.2) | 83 (48.0) | 1.00 | 0.171 | 1.00 | 0.531 |
| CT | 58 (43.6) | 54 (50.5) | 72 (41.6) | 0.58 (0.32–1.06) | 1.41 (0.72–2.78) | ||||
| CC | 12 (9.0) | 11 (10.3) | 18 (10.4) | 0.56 (0.20–1.55) | 0.87 (0.26–2.86) | ||||
| Dominant | TT | 63 (47.4) | 42 (39.2) | 83 (48.0) | 1.00 | 0.062 | 1.00 | 0.422 | |
| CT–CC | 70 (52.6) | 65 (60.8) | 90 (52.0) | 0.58 (0.32–1.03) | 1.30 (0.68–2.48) | ||||
| Recessive | TT–CT | 121 (91.0) | 96 (89.7) | 155 (89.6) | 1.00 | 0.552 | 1.00 | 0.600 | |
| CC | 12 (9.0) | 11 (10.3) | 18 (10.4) | 0.75 (0.29–1.95) | 0.74 (0.23–2.33) | ||||
| Super-dominance | TT–CC | 75 (56.4) | 53 (49.5) | 101 (58.4) | 1.00 | 0.134 | 1.00 | 0.270 | |
| CT | 58 (43.6) | 54 (50.5) | 72 (41.6) | 0.65 (0.37–1.15) | 1.44 (0.75–2.78) | ||||
| Alleles | T | 184 (69.2) | 138 (64.5) | 238 (68.8) | 1.00 | 0.278 | 1.00 | 0.768 | |
| C | 82 (30.8) | 76 (35.5) | 108 (31.2) | 0.81 (0.55–1.19) | 1.05 (0.75–1.48) | ||||
| rs3819721 | Co-dominant | GG | 61 (45.9) | 71 (66.3) | 160 (61.3) | 1.00 | 0.021 | 1.00 | 0.160 |
| AG | 58 (43.6) | 31 (29.0) | 57 (33.0) | 2.28 (1.22–4.27) | 0.51 (0.24–1.09) | ||||
| AA | 14 (10.5) | 5 (4.7) | 10 (5.7) | 2.57 (0.72–9.16) | 0.46 (0.11–2.05) | ||||
| Dominant | GG | 61 (45.9) | 71 (66.4) | 106 (61.3) | 1.00 | 0.006 | 1.00 | 0.058 | |
| AG–AA | 72 (54.1) | 36 (33.6) | 67 (38.7) | 2.32 (1.27–4.24) | 0.50 (0.24–1.03) | ||||
| Recessive | GG–AG | 119 (89.5) | 102 (95.3) | 163 (94.2) | 1.00 | 0.363 | 1.00 | 0.450 | |
| AA | 14 (10.5) | 5 (4.7) | 10 (5.8) | 1.75 (0.51–6.03) | 0.57 (0.13–2.47) | ||||
| Super-dominance | GG–AA | 75 (56.4) | 76 (71.0) | 116 (67.0) | 1.00 | 0.022 | 1.00 | 0.110 | |
| AG | 58 (43.6) | 31 (29.0) | 57 (33.0) | 2.04 (1.11–3.76) | 0.54 (0.25–1.15) | ||||
| Alleles | G | 180 (67.7) | 173 (80.8) | 289 (83.5) | 1.00 | 0.001 | 1.00 | < 0.001 | |
| A | 86 (32.3) | 41 (19.2) | 57 (16.5) | 2.02 (1.32–3.09) | 2.42 (1.65–3.55) | ||||
aAdjusted by smoking history, fitness activities and history of TB exposure
bAdjusted by BMI, smoking status, fitness activities, residence, bedroom occupants, indoor humidity and history of TB exposure
Analysis of association between haplotype and pulmonary tuberculosis susceptibility
| Haplotype | TB, | HHC, | HC, | TB vs HHC | TB vs HC | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI)a | OR (95% CI)b | ||||||||||
| TAP1 | |||||||||||
| TT | 164 (61.8) | 149 (69.5) | 259 (75.0) | 1.00 | 1.00 | ||||||
| TC | 34 (12.6) | 37 (17.4) | 37 (10.6) | 0.59 (0.31–1.14) | 0.120 | 0.94 (0.42–2.11) | 0.890 | ||||
| CC | 39 (14.8) | 27 (12.5) | 44 (12.8) | 1.70 (0.92–3.15) | 0.090 | 1.40 (0.72–2.73) | 0.320 | ||||
| CT | 29 (10.8) | 1 (0.6) | 6 (1.6) | 11.34 (1.49–86.56) | 0.020 | 7.45 (1.43–38.76) | 0.018 | ||||
| 0.55 | r2 | 0.19 | 0.61 | r2 | 0.27 | ||||||
| TAP2 | |||||||||||
| TG | 129 (48.6) | 114 (53.2) | (57.5) | 1.00 | 1.00 | ||||||
| CG | 51 (19.1) | 59 (27.6) | (20.2) | 0.74 (0.40–1.38) | 0.350 | 1.17 (0.63–2.17) | 0.61 | ||||
| TA | 55 (20.6) | 24 (11.3) | (11.3) | 2.20 (1.07–4.56) | 0.034 | 0.53 (0.22–1.27) | 0.16 | ||||
| CA | 31 (11.7) | 17 (7.9) | (11.0) | 1.13 (0.45–2.81) | 0.800 | 0.73 (0.29–1.85) | 0.51 | ||||
| D' | 0.29 | r2 | 0.04 | 0.27 | r2 | 0.02 | |||||
aAdjusted by smoking history, fitness activities and history of TB exposure
bAdjusted by BMI, smoking status, fitness activities, residence, bedroom occupants, indoor humidity and history of TB exposure
The relationship between the GRS of TAP gene and tuberculosis susceptibility
| GRSc | TB, | HHC, | HC, | TB vs HHC | TB vs HC | ||
|---|---|---|---|---|---|---|---|
| OR (95% CI)a | OR (95% CI)b | ||||||
| 0–2 | 77 (57.9) | 77 (72.0) | 131 (75.7) | 1.00 | 1.00 | ||
| 3–4 | 44 (33.1) | 27 (25.2) | 31 (20.8) | 1.74 (0.91–3.33) | 0.096 | 2.13 (1.01–4.47) | 0.047 |
| 5–6 | 12 (9.0) | 3 (2.8) | 6 (3.5) | 4.40 (1.09–17.76) | 0.038 | 3.09 (0.84–11.41) | 0.090 |
aAdjusted by smoking history, fitness activities and history of TB exposure
bAdjusted by BMI, smoking status, fitness activities, residence, bedroom occupants, indoor humidity and history of TB exposure
cThe risk alleles at rs1135216, rs1057141, rs241447 and rs3819721 are C, C, C, and A